| Literature DB >> 23638122 |
Xiao-Yun Li1, Li-Ran Pang, Yong-Gui Chen, Shao-Ping Weng, Hai-Tao Yue, Ze-Zhi Zhang, Yi-Hong Chen, Jian-Guo He.
Abstract
In response to endoplasmic reticulum (ER) stress, the signaling pathway termed unfolded protein response (UPR) is activated. To investigate the role of UPR in Litopenaeus vannamei immunity, the activating transcription factor 4 (designated as LvATF4) which belonged to a branch of the UPR, the [protein kinase RNA (PKR)-like ER kinase, (PERK)]-[eukaryotic initiation factor 2 subunit alpha (eIF2α)] pathway, was identified and characterized. The full-length cDNA of LvATF4 was 1972 bp long, with an open reading frame of 1299 bp long that encoded a 432 amino acid protein. LvATF4 was highly expressed in gills, intestines and stomach. For the white spot syndrome virus (WSSV) challenge, LvATF4 was upregulated in the gills after 3 hpi and increased by 1.9-fold (96 hpi) compared to the mock-treated group. The LvATF4 knock-down by RNA interference resulted in a lower cumulative mortality of L. vannamei under WSSV infection. Reporter gene assays show that LvATF4 could upregulate the expression of the WSSV gene wsv023 based on the activating transcription factor/cyclic adenosine 3', 5'-monophosphate response element (ATF/CRE). Another transcription factor of L. vannamei, X box binding protein 1 (designated as LvXBP1), has a significant function in [inositol-requiring enzyme-1(IRE1) - (XBP1)] pathway. This transcription factor upregulated the expression of the WSSV gene wsv083 based on the UPR element (UPRE). These results suggest that in L. vannamei UPR signaling pathway transcription factors are important for WSSV and might facilitate WSSV infection.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23638122 PMCID: PMC3634759 DOI: 10.1371/journal.pone.0062603
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of primers used in this study.
| Primers | Sequence (5′-3′) |
|
| |
| LvATF4-5RACE1 |
|
| LvATF4-5RACE2 |
|
| LvATF4-3RACE1 |
|
| LvATF4-3RACE2 |
|
|
| |
| pACB-LvATF4-Kpn1-F |
|
| pACB-LvATF4-Apa1-R | A |
| pACB-LvXBP1u/s-F |
|
| pACB-LvXBP1u-R |
|
| pACB-LvXBP1s-R |
|
|
| |
| pGL3B-wsv023-Kpn1-F |
|
| pGL3B-wsv023-Bgl2-R |
|
| pGL3B-wsv049-kpn1-F |
|
| pGL3B-wsv049-Hin3-R |
|
| pGL3B-wsv064-Kpn1-F |
|
| pGL3B-wsv064-Bgl2-R |
|
| pGL3B-wsv069-Kpn1-F |
|
| pGL3B-wsv069-Bgl2-R |
|
| pGL3B-wsv138-Kpn1-F |
|
| pGL3B-wsv138-Bgl2-R |
|
| pGL3B-wsv242-Kpn1-F |
|
| pGL3B-wsv242-Bgl2-R |
|
| pGL3B-wsv256-Kpn1-F |
|
| pGL3B-wsv256-Hin3-R |
|
| pGL3B-wsv282-Sac1-F |
|
| pGL3B-wsv282-Bgl2-R |
|
| PGL3B-wsv303-Kpn1-F |
|
| pGL3B-wsv303-Bgl2-R |
|
| pGL3B-wsv306-Kpn1-F |
|
| pGL3B-wsv306-Bgl2-R |
|
| pGL3B-wsv313-Kpn1-F |
|
| pGL3B-wsv313-Bgl2-R |
|
| pGL3B-wsv321-Kpn1-F |
|
| pGL3B-wsv321-Bgl2-R |
|
| pGL3B-wsv343-Kpn1-F |
|
| pGL3B-wsv343-Bgl2-R |
|
| pGL3B-wsv406-Kpn1-F |
|
| pGL3B-wsv406-Bgl2-R |
|
| pGL3B-wsv453-Kpn1-F |
|
| pGL3B-wsv453-Hin3-R |
|
| pGL3B-wsv023dATF/CRE-F |
|
| pGL3B-wsv023mATF/CRE-F | ctcgaaggACTTTCTACGATCTTCTTCACGGA |
| pGL3B-wsv023ATF/CRE-R |
|
| pGL3B-wsv083-Kpn1-F |
|
| pGL3B-wsv083-Xho1-R |
|
| pGL3B-wsv083mATF/CRE-F | aactacacCCAGTGCAGTGTAGTGCCCAAC |
| pGL3B-wsv083ATF/CRE-R |
|
|
| |
| QPCR-LvATF4-F |
|
| QPCR-LvATF4-R |
|
| QPCR-LvEF1α-F |
|
| QPCR-LvEF1α-R |
|
|
| |
| LvATF4-F |
|
| LvATF4-R |
|
|
| |
| DsRNA-LvATF4-T7-F |
|
| DsRNA-LvATF4-R |
|
| DsRNA-LvATF4-F |
|
| DsRNA-LvATF4-T7-R |
|
| DsRNA-eGFP-T7-F |
|
| DsRNA-eGFP-R |
|
| DsRNA-eGFP-F |
|
| DsRNA-eGFP-T7-R |
|
Nucleotides in bold indicate restriction sites introduced for cloning.
Nucleotides in lower-case are the mutant sites.
Figure 1Nucleotide and deduced amino acid sequence of LvATF4.
The ORF of the nucleotide sequences are shown in uppercase letters; the 5′- and 3′-UTRs are shown in lowercase letters. Nucleotides and amino acids are numbered on the left of the sequences. The conserved domains are shaded.
Figure 2Multiple sequence alignment of the LvATF4 proteins.
(A) Schematic representation of the structural domains of LvATFs. (B) The full names of the LvATF4 proteins and their corresponding sequence accession numbers are listed in the legend in Figure 3. The result shows a high homology of amino acid sequences at the conserved domains.
Figure 3Phylogenetic analysis of the ATF4 proteins.
Phylogenetic tree of the ATF4 proteins from invertebrates and vertebrates. The tree was constructed via a neighbor-joining algorithm using the Mega 4.0 program based on the multiple sequence alignment by ClusterX v1.83. The LvATF4 protein is marked with a box. CinATF4, Ciona intestinalis activating transcription factor 4 (GenBank accession no. BAE06319.1); AmaATF4, Amblyomma maculatum activating transcription factor 4 (GenBank accession no. AEO35749.1); CfATF4, Camponotus floridanus activating transcription factor 4 (GenBank accession no.EFN64595.1); GmATF4, Glossina morsitans morsitans activating transcription factor 4 (GenBank accession no.ADD20536.1); OnATF4, Oreochromis niloticus activating transcription factor 4 (GenBank accession no.XP_003443277.1); CidATF4, Ctenopharyngodon idella activating transcription factor 4 (GenBank accession no.AAS57931.1); DrATF4, Danio rerio activating transcription factor 4 (GenBank accession no.NP_001096662.1); XlATF4, Xenopus laevis activating transcription factor 4 (GenBank accession no.NP_001083212.1); GgATF4, Gallus gallusactivating transcription factor 4 (GenBank accession no.BAA76466.1); AmATF4, Ailuropoda melanoleuca activating transcription factor 4 (GenBank accession no.XP_002914604.1); BtATF4, Bos taurus, activating transcription factor 4 (GenBank accession no.NP_001029514.1); OaATF4, Ovis aries activating transcription factor 4 (GenBank accession no.ACJ15469.1); PpATF4, Pan paniscus activating transcription factor 4 (GenBank accession no.XP_003813296.1); CjATF4, Callithrix jacchus activating transcription factor 4 (GenBank accession no.XP_002763954.1); PtATF4, Pan troglodytes activating transcription factor 4 (GenBank accession no.NP_001239446.1); HsATF4, Homo sapiens activating transcription factor 4 (GenBank accession no.NP_877962.1); RnATF4 Rattus norvegicus activating transcription factor 4 (GenBank accession no.AAI58589.1); MmATF4, Mus musculus activating transcription factor 4 (GenBank accession no.AAH85169.1).
Figure 4Expression profiles of LvATF4 in tissues using real-time RT-PCR.
Total RNA extracted from different tissues was reverse-transcribed into cDNA to serve as templates. The relative expression levels were normalized to LvEF1α and the expression of LvATF4 in various tissues were compared against that in the gills. The results are based on three independent experiments and expressed as mean values ± S.D. Statistical significance was determined by one-way ANOVA. Bars with different letters indicate statistical differences (p<0.05).
Figure 5Expression of LATF4 in hemocytes and gill of WSSV challeng shrimp.
The mRNAs were collected at various time points (0, 3, 6, 9, 12, 18, 24, 30, 36, 48, 72, and 96 h) after injection. After the WSSV challenge or PBS injection at various times, the expression level of each gene was measured using real-time RT-PCR. The relative expression of LvATF4 in hemocytes (A), in gills (B) were normalized with LvEF1α and compared against time zero. The bars represent the mean values ± S.D. of three replicates. The statistical significance was calculated using Student’s t-test (* indicates p<0.05 and ** indicates p<0.01 compared with control).
Figure 6Shrimp cumulative mortality following treatment with dsRNAs and experimental infection with WSSV.
(A) RT-PCR analysis of gene expression of LvATF4, the internal control was LvEF1α. Samples were taken 72 h after injection with indicated dsRNA; (B) Shrimp (n = 50) were injected intramuscularly with PBS, dsLvATF4 or dseGFP. 48 h after the initial injection, animals were injected with WSSV or PBS (negative control). Cumulative mortality was recorded every 12 h. Differences in cumulative mortality levels between treatments were analyzed by Kaplan–Meier log-rank χ2 tests.
Figure 7Activation of the wsv023 promoters by LvATF4.
(A) Screening of 15 WSSV gene promoters by LvATF4. (B) Schematic diagram of the wsv023 promoter regions in the luciferase reporter gene constructs. For pGL3-wsv023mATF/CRE, the ATF/CRE in the wsv023 promoters was replaced with (CTCGAAGG); and for pGL3-wsv023dATF/CRE, the ATF/CRE in the wsv023 promoters was deleted (showed as square frame). +1 denotes the transcription initiation site for wsv023, and −1 indicates 1 bp before the translation initiation site. Luc denotes the firefly luciferase reporter gene. (C) Relative luciferase activity in S2 cells. The bars indicate mean values ± S.D. of the luciferase activity (n = 3). The statistical significance was calculated using Student’s t-test (* indicates p<0.05 and ** indicates p<0.01 compared with control).
Figure 8Activation of the wsv083 promoter by LvXBP1s.
Schematic diagram of the wsv083 promoter regions in the luciferase reporter gene constructs. For pGL3-wsv083mUPRE, the UPRE in the wsv083 promoters was replaced with (TGACGTGG). The results were based on three independent experiments and expressed as mean values ± SD. The statistical significance was calculated using Student’s t-test (* indicates p<0.05 and ** indicates p<0.01 compared with control).